Nikang Therapeutics Inc.

AACR abstracts highlight CDK2 inhibition as solution to CDK4/6 resistance and route to reaching more cancer types

Plus: 4DMT hires Noriyuki Kasahara as CSO, and updates from SV, Omega, AbbVie Ventures, Nikang, Immunome, Wugen, Zevra and Quris

Andy Slavitt has stepped down as senior adviser to the Biden administration’s coronavirus pandemic response team; the special government employee position limits service time to 130 days.

With backing from high-profile crossover investors, four-year-old company taking wholly-owned HIF2A program into clinic

Jakafi meets in Phase III for GvHD; low dose Avastin for retinopathy of prematurity